• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

In the past decade there has been a growing interest in understanding sex and gender
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review …

Background: Variants in the DMD gene, that encodes the cytoskeletal protein, dystrophin,
cause a severe form of dilated cardiomyopathy (DCM) associated with high rates of heart …

BACKGROUND: Variants in RBM20 are reported in 2% to 6% of familial cases of dilated
cardiomyopathy and may be associated with fatal ventricular arrhythmia and rapid heart …

Structural, functional and molecular cardiac defects have been reported in spinal muscular
atrophy (SMA) patients and mouse models. Previous quantitative proteomics analyses …

Abstract Background and Aims Emery–Dreifuss muscular dystrophy (EDMD) is caused by
variants in EMD (EDMD1) and LMNA (EDMD2). Cardiac conduction defects and atrial …

Introduction: LMNA-related muscular dystrophy is a rare entity that produce “laminopathies”
such as Emery–Dreifuss muscular dystrophy (EDMD), limb–girdle muscular dystrophy type …

Aims This study aims to determine the familial incidence of dilated (DCM) and hypertrophic
cardiomyopathy (HCM) in first‐degree, second‐degree, and third‐degree relatives of …

Mutations in the nuclear Lamin A/C gene (LMNA) cause diverse degenerative disorders,
including malignant dilated cardiomyopathy in adults. A prevailing hypothesis postulates …

Dilated cardiomyopathy (DCM) is a common cause of non-ischaemic heart failure,
conferring high morbidity and mortality, including sudden cardiac death due to systolic …